{"id":"benzoyl-peroxide-topical","safety":{"commonSideEffects":[{"rate":"10-25","effect":"Skin irritation and erythema"},{"rate":"5-15","effect":"Dryness and peeling"},{"rate":"1-5","effect":"Contact dermatitis"},{"rate":null,"effect":"Bleaching of hair or fabrics"}]},"_chembl":{"chemblId":"CHEMBL1200370","moleculeType":"Small molecule","molecularWeight":"242.23"},"_dailymed":{"setId":"14bf3034-2fe8-44b9-9e26-e804b6046837","title":"BENZOYL PEROXIDE 5% TOPICAL WASH (BENZOYL PEROXIDE) LIQUID BENZOYL PEROXIDE 10% TOPICAL WASH (BENZOYL PEROXIDE) LIQUID [MEDCORE LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Benzoyl peroxide is a topical antimicrobial and keratolytic agent that works through oxidative decomposition to produce benzoic acid and oxygen radicals. These reactive oxygen species are bactericidal against Cutibacterium acnes (formerly Propionibacterium acnes), the primary pathogenic bacterium in acne. Additionally, it promotes desquamation and reduces comedone formation by increasing skin cell turnover.","oneSentence":"Benzoyl peroxide kills acne-causing bacteria and promotes skin cell turnover by generating reactive oxygen species.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:57.013Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris (mild to moderate)"},{"name":"Acne rosacea (adjunctive use)"}]},"trialDetails":[{"nctId":"NCT07473895","phase":"PHASE2","title":"Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT07421804","phase":"NA","title":"Evaluation of Topical Dutasteride as a Potential New Therapy for Facial Acne Vulgaris Versus the Triple Combination Therapy (Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel)","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT07205107","phase":"","title":"Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris","status":"RECRUITING","sponsor":"Bausch Health Americas, Inc.","startDate":"2025-10-02","conditions":"Acne Vulgaris","enrollment":200},{"nctId":"NCT07348978","phase":"NA","title":"Auricular Acupressure Combined With Adapalene for the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2024-11-01","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT05582434","phase":"EARLY_PHASE1","title":"Experience With Topical Acne Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2024-02-15","conditions":"Acne","enrollment":72},{"nctId":"NCT07044024","phase":"","title":"An Observational Clinical Study to Evaluate the Efficacy of the CeraVe Skin Care Line","status":"NOT_YET_RECRUITING","sponsor":"ChinaNorm","startDate":"2025-06-27","conditions":"Acne","enrollment":240},{"nctId":"NCT07015931","phase":"PHASE1, PHASE2","title":"Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2024-11-30","conditions":"Acne Vulgaris","enrollment":23},{"nctId":"NCT06729450","phase":"NA","title":"Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Kane Biotech Inc","startDate":"2026-01-30","conditions":"Acne Vulgaris on the Face","enrollment":24},{"nctId":"NCT04028401","phase":"PHASE3","title":"Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2020-06-19","conditions":"Cutibacterium Acnes Infection","enrollment":110},{"nctId":"NCT06925386","phase":"PHASE2","title":"The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment","status":"NOT_YET_RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2025-05-01","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT06673641","phase":"PHASE1","title":"A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2024-05-13","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT05873933","phase":"NA","title":"An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes","status":"WITHDRAWN","sponsor":"Hemptress","startDate":"2024-07-01","conditions":"Acne, Eczema, Skin Aging","enrollment":""},{"nctId":"NCT05676411","phase":"PHASE4","title":"Benzoyl Peroxide and Electrocautery Skin Incision to Eradicate Cutibacterium Acnes","status":"WITHDRAWN","sponsor":"University of Missouri-Columbia","startDate":"2024-06-01","conditions":"Prosthetic-joint Infection","enrollment":""},{"nctId":"NCT00422240","phase":"PHASE3","title":"Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-06-27","conditions":"Acne Vulgaris","enrollment":1668},{"nctId":"NCT05536882","phase":"PHASE3","title":"MC RCT - BPO vs Adapalene","status":"WITHDRAWN","sponsor":"University of Oklahoma","startDate":"2022-05-18","conditions":"Molluscum Contagiosum","enrollment":""},{"nctId":"NCT06281782","phase":"NA","title":"Platelet-rich Plasma With Topical Retinoids Versus Topical Retinoids Alone in Acne Vulgaris","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"Acne Vulgaris","enrollment":40},{"nctId":"NCT03334682","phase":"PHASE3","title":"Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2018-01-31","conditions":"Acne Vulgaris","enrollment":158},{"nctId":"NCT01044264","phase":"NA","title":"Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2007-12","conditions":"Acne Vulgaris","enrollment":602},{"nctId":"NCT00446043","phase":"PHASE3","title":"Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2004-02-17","conditions":"Acne Vulgaris","enrollment":452},{"nctId":"NCT05855629","phase":"NA","title":"\"A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, and Their Fixed Combination in Mild to Moderate Acne Vulgaris Patients.\"","status":"UNKNOWN","sponsor":"Treatment and Diagnostic Center of Private Enterprise \"Asklepiy\"","startDate":"2022-02-18","conditions":"Acne Vulgaris","enrollment":59},{"nctId":"NCT05675501","phase":"PHASE1","title":"Evaluation of Topical Encapsulated Benzoyl Peroxide on the Skin Microbiome and Skin Biophysical Properties","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2020-06-10","conditions":"Papulopustular Rosacea","enrollment":31},{"nctId":"NCT05497323","phase":"PHASE1","title":"Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad and Zinc PCA","status":"UNKNOWN","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2022-08-01","conditions":"Acne Vulgaris","enrollment":284},{"nctId":"NCT02899000","phase":"PHASE4","title":"A Treatment for Severe Inflammatory Acne Subjects","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-07-29","conditions":"Acne Vulgaris","enrollment":186},{"nctId":"NCT05629468","phase":"PHASE3","title":"Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Pak Emirates Military Hospital","startDate":"2021-10-15","conditions":"Acne Vulgaris","enrollment":75},{"nctId":"NCT02249104","phase":"PHASE4","title":"A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2014-08","conditions":"Acne Vulgaris","enrollment":28},{"nctId":"NCT05096312","phase":"PHASE4","title":"Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients","status":"COMPLETED","sponsor":"East Avenue Medical Center, Philippines","startDate":"2018-12-21","conditions":"Acne Vulgaris","enrollment":23},{"nctId":"NCT04300010","phase":"PHASE4","title":"Blue Light Therapy of C. Acnes","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-10-05","conditions":"Acne","enrollment":60},{"nctId":"NCT03573115","phase":"NA","title":"Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery","status":"COMPLETED","sponsor":"Merete Haedersdal","startDate":"2018-01-04","conditions":"Acne Vulgaris, Microparticles","enrollment":16},{"nctId":"NCT01818167","phase":"NA","title":"An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2013-01-05","conditions":"Hidradenitis Suppurativa","enrollment":25},{"nctId":"NCT05216289","phase":"PHASE4","title":"The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the Treatment of Acne","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2018-04-01","conditions":"Acne Vulgaris","enrollment":400},{"nctId":"NCT03761810","phase":"PHASE3","title":"A Study of S6G5T3 in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-12-14","conditions":"Acne Vulgaris","enrollment":434},{"nctId":"NCT03761784","phase":"PHASE3","title":"A Study of S6G5T-3 in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-12-21","conditions":"Acne Vulgaris","enrollment":424},{"nctId":"NCT03564119","phase":"PHASE3","title":"A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-06-21","conditions":"Papulopustular Rosacea","enrollment":372},{"nctId":"NCT03564145","phase":"PHASE3","title":"A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea","status":"TERMINATED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-09-12","conditions":"Papulopustular Rosacea","enrollment":547},{"nctId":"NCT03448939","phase":"PHASE3","title":"A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea","status":"COMPLETED","sponsor":"Sol-Gel Technologies, Ltd.","startDate":"2018-06-18","conditions":"Papulopustular Rosacea","enrollment":361},{"nctId":"NCT03393494","phase":"PHASE3","title":"Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2017-12-13","conditions":"Acne Vulgaris","enrollment":825},{"nctId":"NCT01796665","phase":"PHASE3","title":"A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2012-02","conditions":"Acne","enrollment":1180},{"nctId":"NCT03832647","phase":"PHASE4","title":"Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne","status":"COMPLETED","sponsor":"Vichy Laboratoires","startDate":"2019-02-18","conditions":"Acne","enrollment":200},{"nctId":"NCT01138514","phase":"PHASE3","title":"Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2009-10","conditions":"Acne Vulgaris","enrollment":1555},{"nctId":"NCT04216160","phase":"NA","title":"Skin Acceptance and Efficacy Assessment of a Topical Product in Acne Treatment When Compared to a Placebo.","status":"COMPLETED","sponsor":"YUN NV","startDate":"2019-05-05","conditions":"Acne Vulgaris","enrollment":80},{"nctId":"NCT03563365","phase":"PHASE4","title":"The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol","status":"TERMINATED","sponsor":"Yardley Dermatology Associates","startDate":"2018-06-04","conditions":"Acne Vulgaris","enrollment":43},{"nctId":"NCT00421993","phase":"PHASE3","title":"A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-10","conditions":"Acne Vulgaris","enrollment":1670},{"nctId":"NCT00687908","phase":"PHASE3","title":"Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-11","conditions":"Acne","enrollment":243},{"nctId":"NCT01138735","phase":"PHASE4","title":"Epiduo Pediatric Acne Study","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2010-06","conditions":"Acne","enrollment":285},{"nctId":"NCT00688064","phase":"PHASE3","title":"Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-08","conditions":"Severe Acne Vulgaris","enrollment":459},{"nctId":"NCT01474590","phase":"PHASE3","title":"Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-11","conditions":"Acne","enrollment":266},{"nctId":"NCT03709654","phase":"PHASE1","title":"A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne","status":"COMPLETED","sponsor":"Naked Biome, Inc.","startDate":"2018-11-01","conditions":"Acne Vulgaris","enrollment":36},{"nctId":"NCT02651220","phase":"PHASE3","title":"Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2015-11","conditions":"Acne","enrollment":1001},{"nctId":"NCT02616614","phase":"PHASE3","title":"Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2015-05","conditions":"Acne Vulgaris","enrollment":862},{"nctId":"NCT03650881","phase":"NA","title":"The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2018-08-07","conditions":"Acne","enrollment":""},{"nctId":"NCT03257202","phase":"PHASE2","title":"Topical Treatment and Prevalence of P. Acnes","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2017-09-11","conditions":"Surgical Site Infection","enrollment":12},{"nctId":"NCT01237821","phase":"NA","title":"Comparing OTC Acne Treatment to Prescription Regimen","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2010-10","conditions":"Acne Vulgaris","enrollment":66},{"nctId":"NCT03457636","phase":"PHASE4","title":"The Use of Oracea and Epiduo Forte in Severe Acne Patients","status":"COMPLETED","sponsor":"Derm Research, PLLC","startDate":"2018-03-19","conditions":"Acne","enrollment":22},{"nctId":"NCT03124381","phase":"NA","title":"A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer Inc. (J&JCI)","startDate":"2017-04-08","conditions":"Acne Vulgaris","enrollment":126},{"nctId":"NCT02731105","phase":"PHASE4","title":"Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products","status":"COMPLETED","sponsor":"GWT-TUD GmbH","startDate":"2015-02","conditions":"Acne Vulgaris","enrollment":22},{"nctId":"NCT01504204","phase":"PHASE4","title":"Effect of Samples on Acne Treatment With Epiduo® Gel","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2011-12","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT00658112","phase":"PHASE4","title":"Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2006-07","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT01176955","phase":"NA","title":"A Novel Method to Improve Acne Outcomes","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2009-05","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT01445301","phase":"PHASE3","title":"Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-09-27","conditions":"Acne Vulgaris","enrollment":800},{"nctId":"NCT00558831","phase":"NA","title":"Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2007-10","conditions":"Acne Vulgaris","enrollment":11},{"nctId":"NCT01948570","phase":"","title":"Clinical Study for the Evaluation of P-3075 Cream on Acne Treatment","status":"COMPLETED","sponsor":"Derming SRL","startDate":"2013-03","conditions":"Acne","enrollment":40},{"nctId":"NCT02058628","phase":"PHASE4","title":"Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02-21","conditions":"Acne Vulgaris","enrollment":222},{"nctId":"NCT00757523","phase":"PHASE4","title":"Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-09-10","conditions":"Acne Vulgaris","enrollment":382},{"nctId":"NCT02465632","phase":"PHASE3","title":"To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2015-04","conditions":"Acne Vulgaris","enrollment":1100},{"nctId":"NCT01132443","phase":"PHASE1","title":"W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2010-05-06","conditions":"Acne Vulgaris","enrollment":72},{"nctId":"NCT00964366","phase":"PHASE4","title":"Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":53},{"nctId":"NCT00841776","phase":"PHASE4","title":"Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2007-08","conditions":"Acne","enrollment":54},{"nctId":"NCT00891982","phase":"PHASE3","title":"A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-04-01","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT02709902","phase":"PHASE1","title":"Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-09","conditions":"Acne Vulgaris","enrollment":460},{"nctId":"NCT02595034","phase":"PHASE1","title":"A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2015-01","conditions":"Acne Vulgaris","enrollment":1000},{"nctId":"NCT01015638","phase":"PHASE4","title":"Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":36},{"nctId":"NCT00887484","phase":"PHASE4","title":"A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":50},{"nctId":"NCT00964223","phase":"PHASE4","title":"A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-07","conditions":"Acne Vulgaris","enrollment":28},{"nctId":"NCT01618773","phase":"","title":"Long-term Study of Epiduo in Patients With Moderate to Severe Acne","status":"COMPLETED","sponsor":"Galderma Laboratorium GmbH","startDate":"2012-06","conditions":"Acne Vulgaris","enrollment":6036},{"nctId":"NCT01220102","phase":"","title":"Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne","status":"COMPLETED","sponsor":"Galderma Laboratorium GmbH","startDate":"2010-05","conditions":"Acne","enrollment":3113},{"nctId":"NCT01613924","phase":"PHASE4","title":"Efficacy of Handheld Acne Heat Device","status":"WITHDRAWN","sponsor":"University of British Columbia","startDate":"2013-07","conditions":"Acne Vulgaris","enrollment":""},{"nctId":"NCT00926367","phase":"PHASE4","title":"Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-05","conditions":"Acne Vulgaris","enrollment":52},{"nctId":"NCT00787943","phase":"NA","title":"Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2008-05","conditions":"Acne Vulgaris","enrollment":10},{"nctId":"NCT02313467","phase":"NA","title":"Topical PDT Cream Without Irradiation Source in the Acne Treatment","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-01","conditions":"Acne, Photodynamic Therapy","enrollment":45},{"nctId":"NCT01400932","phase":"PHASE3","title":"Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":360},{"nctId":"NCT02126709","phase":"PHASE2","title":"The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2014-06","conditions":"Acne","enrollment":30},{"nctId":"NCT01769664","phase":"PHASE1","title":"A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2012-09","conditions":"Acne Vulgaris","enrollment":650},{"nctId":"NCT01387048","phase":"PHASE4","title":"Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin","status":"COMPLETED","sponsor":"University of Magdeburg","startDate":"2011-08","conditions":"Acne Vulgaris","enrollment":60},{"nctId":"NCT01788384","phase":"PHASE3","title":"Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris","status":"COMPLETED","sponsor":"Watson Laboratories, Inc.","startDate":"2012-07","conditions":"Acne Vulgaris","enrollment":708},{"nctId":"NCT01231334","phase":"PHASE4","title":"A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne","status":"COMPLETED","sponsor":"Allergan","startDate":"2010-08","conditions":"Acne Vulgaris","enrollment":286},{"nctId":"NCT00807014","phase":"PHASE4","title":"Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2006-11","conditions":"Acne Vulgaris","enrollment":169},{"nctId":"NCT01501799","phase":"NA","title":"A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Actavis Mid-Atlantic LLC","startDate":"2011-07","conditions":"Acne Vulgaris","enrollment":885},{"nctId":"NCT01206348","phase":"PHASE4","title":"Combination Treatment for Moderate to Severe Acne","status":"COMPLETED","sponsor":"Medicis Global Service Corporation","startDate":"2010-09","conditions":"Acne","enrollment":97},{"nctId":"NCT00151541","phase":"PHASE3","title":"A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%","status":"COMPLETED","sponsor":"Allergan","startDate":"2005-02","conditions":"Acne Vulgaris","enrollment":301},{"nctId":"NCT01260571","phase":"PHASE4","title":"Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)","status":"UNKNOWN","sponsor":"Zurita Laboratorio Farmaceutico Ltda.","startDate":"2011-01","conditions":"Treatment of Acne Vulgaris Grade II in a Short Period of Time.","enrollment":62},{"nctId":"NCT01052246","phase":"NA","title":"Pulsed Dye Laser Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Laserklinik Karlsruhe","startDate":"2008-10","conditions":"Acne Vulgaris","enrollment":80},{"nctId":"NCT00877409","phase":"PHASE3","title":"Safety and Efficacy Study of Acnase Creme in the Treatment of Acne Vulgaris I and II","status":"UNKNOWN","sponsor":"Zurita Laboratorio Farmaceutico Ltda.","startDate":"2009-04","conditions":"Acne Vulgaris","enrollment":80},{"nctId":"NCT00664248","phase":"PHASE3","title":"A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris","status":"COMPLETED","sponsor":"Dow Pharmaceutical Sciences","startDate":"2006-10","conditions":"Acne Vulgaris","enrollment":1414},{"nctId":"NCT00663286","phase":"PHASE3","title":"A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris","status":"COMPLETED","sponsor":"Dow Pharmaceutical Sciences","startDate":"2006-10","conditions":"Acne Vulgaris","enrollment":1399}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"DRUG INEFFECTIVE"},{"count":2,"reaction":"PRODUCT PHYSICAL CONSISTENCY ISSUE"},{"count":1,"reaction":"ACNE"},{"count":1,"reaction":"BURNING SENSATION"},{"count":1,"reaction":"DRUG DOSE OMISSION"},{"count":1,"reaction":"EXPIRED PRODUCT ADMINISTERED"},{"count":1,"reaction":"OFF LABEL USE"},{"count":1,"reaction":"PARAESTHESIA"},{"count":1,"reaction":"PRODUCT PHYSICAL ISSUE"},{"count":1,"reaction":"PRODUCT QUALITY ISSUE"}],"_approvalHistory":[],"publicationCount":22,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Benzoyl Peroxide Topical","genericName":"Benzoyl Peroxide Topical","companyName":"University of Missouri-Columbia","companyId":"university-of-missouri-columbia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Benzoyl peroxide kills acne-causing bacteria and promotes skin cell turnover by generating reactive oxygen species. Used for Acne vulgaris (mild to moderate), Acne rosacea (adjunctive use).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}